Company intelligence / Profile preview

OCIM Pharmaceuticals

Pine Brook, New Jersey, United Statesocimpharma.com ↗

Ownership: Private
Employees: ~50
Development stage: Preclinical

Overview

OCIM Pharmaceuticals is an R&D-based pharmaceutical company focused on developing complex and difficult-to-make generic products for the US market. They maintain stringent quality control measures throughout the product development process, including rigorous testing and clinical trials[6].

Modalities: Generic pharmaceuticals
Industry: Biotech

Partnerships

1 collaboration mentioned but details not provided[1]

Beyond the preview

Go deeper on OCIM Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on OCIM Pharmaceuticals.

Explore the full profile